Fluselenamyl in conjuction with positron emission tomography (PET) scans shown effective in diagnosing early Alzheimer’s disease pathology

Researchers at Washington University School of Medicine in St. Louis have developed a chemical compound, named Fluselenamyl, that detects amyloid clumps better than current FDA-approved compounds. If a radioactive atom is incorporated into the compound, its location in a living brain can be monitored using positron emission tomography (PET) scans. The compound, described in a paper … Continue reading Fluselenamyl in conjuction with positron emission tomography (PET) scans shown effective in diagnosing early Alzheimer’s disease pathology

Understanding pathology behind triple negative breast cancer

A study conducted at the Research Institute of the McGill University Health Centre (RI-MUHC) suggests screening breast cancer patients for the prolactin receptor could improve the prognosis for patient and may help them avoid unnecessary and invasive treatments. Using a database of 580 women with triple negative breast cancer (TNBC), the researchers found that survival … Continue reading Understanding pathology behind triple negative breast cancer

Onionin A, natural compound from onions found effective against Epithelial Ovarian Cancer

Research from Kumamoto University, Japan has found that a natural compound isolated from onions, onionin A (ONA), has several anti-ovarian cancer properties. This discovery is a result of research on the effects of onionin A on a preclinical model of epithelial ovarian cancer (EOC) both in vivo and in vitro. This research comes from the … Continue reading Onionin A, natural compound from onions found effective against Epithelial Ovarian Cancer